Excelas announces new ownership

Chase Zaputil
Stay current with healthcare and senior care provider regulatory trends, news and solutions delivered right to your inbox. Sign up for our newsletter.

Get Solutions

EXCCELAS

Reinforcing stability, expertise and client commitment

Excelas, a trusted provider of medical-legal analysis for more than 20 years, announced that Chase Zaputil has assumed ownership of the company. The transition marks a new chapter grounded in continuity, operational stability and an ongoing commitment to the high standards clients expect.

Under Zaputil’s ownership, Excelas will continue delivering the same expert-driven medical-legal analysis that has defined the firm for two decades. The company’s core strengths of deep clinical insight, rigorous review processes and a client-first approach remain firmly in place. Clients can expect uninterrupted service, consistent quality and the same experienced team supporting their work.

“Excelas has built a strong reputation by doing the fundamentals exceptionally well,” Zaputil said. “Our clients rely on accuracy, clarity and sound judgment, and that does not change. We will continue to invest thoughtfully to support our team and enhance the value we deliver.”

Jean Bourgeois, who founded and led Excelas’ operations as its president, emphasized the importance of continuity throughout the transition. “This change in ownership is about strengthening what already works,” Bourgeois said. “Chase brings a deep understanding of healthcare, technology and disciplined execution, while fully respecting the expertise, relationships and culture that have made Excelas successful. Our clients should feel confident that Excelas remains steady, focused and committed to excellence.”

With its leadership team, staff and service model intact, and Jean staying on in an advisory position, Excelas enters this next phase from a position of strength. The company remains dedicated to providing reliable, expert-led medical-legal analysis with integrity, consistency and a forward-looking mindset for years to come.

VALUE-BASED HEALTHCARE INNOVATION

CMMI debuts ACCESS Model to spur use of tech in chronic disease treatment

The Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model is a 10-year payment program that would offer stable, recurring payments for technology used to treat diabetes, hypertension, chronic kidney disease, obesity, depression and anxiety.

Certain software-based health technologies, such as prescription digital therapeutics, have not traditionally been covered by Medicare due to limitations in the Medicare statute. Under the ACCESS Model, novel technologies cleared by the Food and Drug Administration could prove themselves based on the outcomes they produce.

The Center for Medicare and Medicaid Innovation (CMMI) plans to use outcomes-aligned payments to cover the cost of technology for Medicare providers if a patient with a qualifying chronic condition achieves clinically significant results, like lowering their blood pressure.

Provider organizations must be enrolled in Medicare Part B to participate in the model. The CMMI is accepting applications on a rolling basis from 2026 to 2033.

While the initial ACCESS model would allow Medicare beneficiaries to benefit from health technology for the treatment and management of chronic conditions, other healthcare payers have now signed on to a pledge that would expand the model to the Medicare Advantage, Medicaid and commercial markets.

The voluntary model focuses on conditions affecting more than two-thirds of people with Medicare, including high blood pressure, diabetes, chronic musculoskeletal pain and depression. It will help pay for telehealth software, wearables and wellness apps that address the conditions.

DIGITAL PREVENTION TECHNOLOGIES

Bundling digital falls prevention technology

Falls are the leading cause of injury for older adults — one in four reports falling each year, leading to 3 million emergency department visits, more than 1 million annual hospitalizations, and medical expenditures projected to reach $100 billion by 2030.

The Milken Institute has developed a blueprint to help senior living providers group and evaluate the deluge of falls prevention technologies on the market. The report’s recommendations aim to provide a starting point to simplify purchases, provide implementation efficiencies, improve overall user experience and adopting, and more effectively treat and prevent falls.

Grouping falls prevention technologies by their primary purpose: assessment, prevention, intervention or response, alleviates decision-making burdens, optimizes user benefits and improves health outcomes.

“The need for action is urgent because the number of older adults requiring this technology increases each year,” the authors concluded.

IN THEIR OWN WORDS – TESTIMONIAL

Medical Record Organization

Excelas helps organizations respond accurately and quickly to claims and litigation brought against them

Partnering with attorneys, health care organizations, and insurance companies since 1995, Excelas provides medical legal analyses and tools for building winning defense strategies. When expertise, accuracy, reliability, and on-time delivery count, you can count on Excelas.

Post Tags: